Syndax Pharmaceuticals, Inc. · NASDAQ:SNDX
Syndax Pharmaceuticals, Inc. shareholders
As of Jun 30, 2026, 235 institutions reported holding Syndax Pharmaceuticals, Inc. Largest: BlackRock, Kynam Capital Management, LP and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Syndax Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 9.02M | +766K | Aug 7, 2026 | |
| Kynam Capital Management, LP | 8.05M | no change | Aug 14, 2026 | |
| Vanguard | 6.6M | +326K | Aug 13, 2026 | |
| Goldman Sachs | 5.86M | +864K | Aug 14, 2026 | |
| State Street | 5.66M | +1.23M | Aug 7, 2026 | |
| Bank of America | 4.05M | −205K | Aug 14, 2026 | |
| Deerfield Management Company, L.P. | 3.78M | no change | Aug 14, 2026 | |
| Eversept Partners, LP | 2.8M | −87,412 | Aug 14, 2026 | |
| Geode Capital | 2.58M | +427K | Aug 12, 2026 | |
| Hood River Capital Management LLC | 2.56M | +210K | Aug 14, 2026 |